In the present study (Figures 2– 4), we have confirmed that α -MG treatment can dramatically activate AMPK and inhibited NOX4 expression as well as TGF-β1/Smad2/3 signaling pathway in lung tissues compared with the BLM alone group. The gene discussed is NOX4; the disease is Bloom syndrome.